Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation†
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, a mutation at the β′-site (E682K [87]) causes AD by shifting BACE1 cleavage toward β-site processing of APP and Aβ generation.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 2×
“EMBO Mol Med 3, 291–302 www.embomolmed.org Values are mean SD. b0-site was originally discovered in cell cultures overexpressing this protease (Vassar et al, 1999).”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 1×
“…production, but most affect the ratio of different Ab peptides without increasing total Ab, favouring a relative increase in Ab42 versus other species (Bentahir et al, 2006; Citron et al, 1992; De Jonghe et al, 2001; Di Fede et al, 2009; Kwok et al, 2000; Scheuner et al, 1996; Suzuki et al, 1994).”
BackgroundMembrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · cited 1×
“BACE1, a membrane-bound aspartic protease, is the bsecretase, which cleaves APP at the b-site Met671–Asp672 of APP (Asp1 of the Ab sequence; Hussain et al, 1999; Lin et al, 2000; Sinha et al, 1999; Vassar et al, 1999; Yan et al, 1999).”
BackgroundThe 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209 · cited 2×
“Those affect either the generation of Ab by the secretases, the aggregation properties of the Ab peptide or its proteolytic degradation (Betts et al, 2008; Nilsberth et al, 2001; Ono et al, in press; Tomiyama et al, 2008; Tsubuki et al, 2003).”
BackgroundIdentification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Kawashima, M., Funamoto, S., & Ihara, Y. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2362-09.2009 · Cited by 498
Research works printed but not linked: 36
- Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, Cupers P, Craessaerts K, De Strooper B (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32: 579‐589 · DOI · Paper page
- Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, Esselmann H, De Strooper B (2006) Presenilin clinical mutations can affect gamma‐secretase activity by different mechanisms. J Neurochem 96: 732‐742 · DOI · Paper page
- Betts V, Leissring MA, Dolios G, Wang R, Selkoe DJ, Walsh DM (2008) Aggregation and catabolism of disease‐associated intra‐Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin. Neurobiol Dis 31: 442‐450 · DOI
- Brouwers N, Sleegers K, Van Broeckhoven C (2008) Molecular genetics of Alzheimer's disease: an update. Ann Med 40: 562‐583 · DOI · Paper page
- Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, Craessaerts K, Annaert W, De Strooper B (2001) Processing of beta‐secretase by furin and other members of the proprotein convertase family. J Biol Chem 276: 4211‐4217 · DOI · Paper page
- De Strooper B, Annaert W (2010) Novel research horizons for presenilins and gamma‐secretases in cell biology and disease. Annu Rev Cell Dev Biol 26: 235‐260 · DOI · Paper page
- De Strooper B, Simons M, Multhaup G, Van Leuven F, Beyreuther K, Dotti CG (1995) Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J 14: 4932‐4938 · DOI · Paper page
- Demeester N, Mertens C, Caster H, Goethals M, Vandekerckhove J, Rosseneu M, Labeur C (2001) Comparison of the aggregation properties, secondary structure and apoptotic effects of wild‐type, Flemish and Dutch N‐terminally truncated amyloid beta peptides. Eur J Neurosci 13: 2015‐2024 · DOI
- Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, Merlin M, Giovagnoli AR, Prioni S, Erbetta A, et al (2009) A recessive mutation in the APP gene with dominant‐negative effect on amyloidogenesis. Science 323: 1473‐1477 · DOI · Paper page
- Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, et al (2010) Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging 31: 725‐731 · DOI · Paper page
- Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta‐protein precursor. J Biol Chem 269: 17741‐17748 · DOI · Paper page
- Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, et al (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta‐amyloid precursor protein gene. Nat Genet 1: 218‐221 · DOI · Paper page
- Hoey SE, Williams RJ, Perkinton MS (2009) Synaptic NMDA receptor activation stimulates alpha‐secretase amyloid precursor protein processing and inhibits amyloid‐beta production. J Neurosci 29: 4442‐4460 · DOI · Paper page
- Huse JT, Liu K, Pijak DS, Carlin D, Lee VM, Doms RW (2002) Beta‐secretase processing in the trans‐golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J Biol Chem 277: 16278‐16284 · DOI · Paper page
- Kimberly WT, Zheng JB, Town T, Flavell RA, Selkoe DJ (2005) Physiological regulation of the beta‐amyloid precursor protein signaling domain by c‐Jun N‐terminal kinase JNK3 during neuronal differentiation. J Neurosci 25: 5533‐5543 · DOI · Paper page
- Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, et al (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound‐B. Ann Neurol 55: 306‐319 · DOI · Paper page
- Kwok JB, Li QX, Hallupp M, Whyte S, Ames D, Beyreuther K, Masters CL, Schofield PR (2000) Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis. Ann Neurol 47: 249‐253 · doi:10.1002/1531-8249(200002)47:2<249::aid-ana18>3.0.co;2-8
- Lichtenthaler SF, Multhaup G, Masters CL, Beyreuther K (1999) A novel substrate for analyzing Alzheimer's disease gamma‐secretase. FEBS Lett 453: 288‐292 · DOI · Paper page
- Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J (2000) Human aspartic protease memapsin 2 cleaves the beta‐secretase site of beta‐amyloid precursor protein. Proc Natl Acad Sci USA 97: 1456‐1460 · DOI · Paper page
- Liu K, Doms RW, Lee VM (2002) Glu11 site cleavage and N‐terminally truncated Abeta production upon BACE overexpression. Biochemistry 41: 3128‐3136 · DOI · Paper page
- Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM (2006) Characterization of Abeta11‐40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N‐terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Acta Neuropathol 112: 163‐174 · DOI
- Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, Van Laere K, Bormans G, Vandenberghe R (2007) Abeta amyloid deposition in the language system and how the brain responds. Brain 130: 2055‐2069 · DOI · Paper page
- Ono K, Condron MM, Teplow DB Effects of the english (H6R) and tottori (D7N) familial Alzheimer disease mutations on amyloid {beta}‐protein assembly and toxicity. J Biol Chem 285: 23186‐23197 · DOI · Paper page
- Qahwash I, He W, Tomasselli A, Kletzien RF, Yan R (2004) Processing amyloid precursor protein at the beta‐site requires proper orientation to be accessed by BACE1. J Biol Chem 279: 39010‐39016 · DOI · Paper page
- Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI, Lin C, Liang Y, et al (1996) Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 5: 985‐988 · DOI · Paper page
- Singleton AB, Hardy J, Traynor BJ, Houlden H (2010) Towards a complete resolution of the genetic architecture of disease. Trends Genet 26: 438‐442 · DOI · Paper page
- Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, et al (1999) Purification and cloning of amyloid precursor protein beta‐secretase from human brain. Nature 402: 537‐540 · DOI · Paper page
- Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Jr., Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1336‐1340 · DOI · Paper page
- Theuns J, Marjaux E, Vandenbulcke M, Van Laere K, Kumar‐Singh S, Bormans G, Brouwers N, Van den Broeck M, Vennekens K, Corsmit E, et al (2006) Alzheimer dementia caused by a novel mutation located in the APP C‐terminal intracytosolic fragment. Hum Mutat 27: 888‐896 · DOI · Paper page
- Tian Y, Bassit B, Chau D, Li YM (2010) An APP inhibitory domain containing the Flemish mutation residue modulates gamma‐secretase activity for Abeta production. Nat Struct Mol Biol 17: 151‐158 · DOI
- Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, et al (2008) A new amyloid beta variant favoring oligomerization in Alzheimer's‐type dementia. Ann Neurol 63: 377‐387 · DOI · Paper page
- Tsubuki S, Takaki Y, Saido TC (2003) Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet 361: 1957‐1958 · DOI · Paper page
- Turner RT, III, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK, Tang J (2001) Subsite specificity of memapsin 2 (beta‐secretase): implications for inhibitor design. Biochemistry 40: 10001‐10006 · DOI · Paper page
- Weckx S, Del‐Favero J, Rademakers R, Claes L, Cruts M, De Jonghe P, Van Broeckhoven C, De Rijk P (2005) NovoSNP, a novel computational tool for sequence variation discovery. Genome Res 15: 436‐442 · DOI · Paper page
- Wilquet V, De Strooper B (2004) Amyloid‐beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14: 582‐588 · DOI · Paper page
- Yang HC, Chai X, Mosior M, Kohn W, Boggs LN, Erickson JA, McClure DB, Yeh WK, Zhang L, Gonzalez‐DeWhitt P, et al (2004) Biochemical and kinetic characterization of BACE1: investigation into the putative species‐specificity for beta‐ and beta'‐cleavage sites by human and murine BACE1. J Neurochem 91: 1249‐1259 · DOI
Cited by
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629
“Nevertheless, all nine mutations are expected on theoretical grounds to increase the aggregation rate of the intrinsically disordered Aβ peptides, and for a number of them the predictions have been verified experimentally (54, 58, 59).”
The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease
Chávez‐Gutiérrez, L., Bammens, L., Benilova, I., Vandersteen, A., Benurwar, M., Borgers, M., Lismont, S., Zhou, L., Van Cleynenbreugel, S., Esselmann, H., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.79 · Cited by 495
“Detection antibody was obtained from Jansen; huAB25-HRPO (Zhou et al , 2011).”
Self-citationSadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294
Ochalek, A., Mihalik, B., Avci, H. X., Chandrasekaran, A., Téglási, A., Bock, I., Giudice, M. L., Táncos, Z., Molnár, K., László, L., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0317-z · Cited by 225
“For instance, PSEN mutations lead to a partial loss of function in the γ-secretase complex and consequently to incomplete Aβ digestion [18], whereas most of the mutations in APP have been found to increase production of Aβ peptides [19].”
BackgroundUntangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223
Metadata
- Authors
- Zhou, L., Brouwers, N., Benilova, I., Vandersteen, A., Mercken, M., Van Laere, K., Van Damme, P., Demedts, D., Van Leuven, F., Sleegers, K., Broersen, K., Van Broeckhoven, C., Vandenberghe, R., & De Strooper, B.
- Venue
- EMBO Molecular Medicine
- Published
- 2011-04-15
- Volume
- 3
- Issue
- 5
- Pages
- 291-302
- ISSN
- 1757-4676
- 1757-4684
- Cited by
- 109
- References
- 13
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- KULeuven and the Flemisch government
- Methusalem grant of the Special Research Fund of the University of Antwerp and Flemish government
- Fund for Scientific Research Flanders
- Foundation for Alzheimer Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation†. https://app.cochat.ai/papers/10.1002/emmm.201100138
- The paper
- Zhou, L., Brouwers, N., Benilova, I., Vandersteen, A., Mercken, M., Van Laere, K., Van Damme, P., Demedts, D., Van Leuven, F., Sleegers, K., Broersen, K., Van Broeckhoven, C., Vandenberghe, R., & De Strooper, B. (2011). Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation†. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201100138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.